Standard

Statins and Autoimmunity. / Gurevich, Victor S.

The Hearth in Systemic Autoimmune Diseases. ed. / A. Doria; P. Pauletto. Vol. 1 Elsevier, 2004. p. 97-106 (Handbook of Systemic Autoimmune Diseases; Vol. 1).

Research output: Chapter in Book/Report/Conference proceedingChapterResearchpeer-review

Harvard

Gurevich, VS 2004, Statins and Autoimmunity. in A Doria & P Pauletto (eds), The Hearth in Systemic Autoimmune Diseases. vol. 1, Handbook of Systemic Autoimmune Diseases, vol. 1, Elsevier, pp. 97-106. https://doi.org/10.1016/S1571-5078(03)01007-9

APA

Gurevich, V. S. (2004). Statins and Autoimmunity. In A. Doria, & P. Pauletto (Eds.), The Hearth in Systemic Autoimmune Diseases (Vol. 1, pp. 97-106). (Handbook of Systemic Autoimmune Diseases; Vol. 1). Elsevier. https://doi.org/10.1016/S1571-5078(03)01007-9

Vancouver

Gurevich VS. Statins and Autoimmunity. In Doria A, Pauletto P, editors, The Hearth in Systemic Autoimmune Diseases. Vol. 1. Elsevier. 2004. p. 97-106. (Handbook of Systemic Autoimmune Diseases). https://doi.org/10.1016/S1571-5078(03)01007-9

Author

Gurevich, Victor S. / Statins and Autoimmunity. The Hearth in Systemic Autoimmune Diseases. editor / A. Doria ; P. Pauletto. Vol. 1 Elsevier, 2004. pp. 97-106 (Handbook of Systemic Autoimmune Diseases).

BibTeX

@inbook{7c89ac68ceea43f1924efbb54543cb16,
title = "Statins and Autoimmunity",
abstract = "Statins may provide benefits, both by decreasing cholesterol and by the use of lipid-independent mechanisms. Extensive research carried out recently suggests that the clinical benefits of these drugs could be related to an improvement in endothelial dysfunction, a reduction in blood thrombogenicity, anti-inflammatory properties, and immunomodulatory actions. It is thought that they will become valuable tools for controlling inflammatory and immune responses. The chapter discusses the positive role of statins in the treatment of autoimmune reactions. The identification of several mechanisms through which statins decrease the recruitment of macrophages and T cells into the arterial wall and inhibit T-cell activation and proliferation in vitro have confirmed speculations that the immunomodulatory effects of statins may also be beneficial in the prevention of cardiovascular events. Many of these effects are related to the inhibition of isoprenoid synthesis, which serves as a lipid attachment for a variety of proteins implicated in intracellular signaling.",
author = "Gurevich, {Victor S.}",
year = "2004",
doi = "10.1016/S1571-5078(03)01007-9",
language = "English",
isbn = "9780444513984",
volume = "1",
series = "Handbook of Systemic Autoimmune Diseases",
publisher = "Elsevier",
pages = "97--106",
editor = "A. Doria and P. Pauletto",
booktitle = "The Hearth in Systemic Autoimmune Diseases",
address = "Netherlands",

}

RIS

TY - CHAP

T1 - Statins and Autoimmunity

AU - Gurevich, Victor S.

PY - 2004

Y1 - 2004

N2 - Statins may provide benefits, both by decreasing cholesterol and by the use of lipid-independent mechanisms. Extensive research carried out recently suggests that the clinical benefits of these drugs could be related to an improvement in endothelial dysfunction, a reduction in blood thrombogenicity, anti-inflammatory properties, and immunomodulatory actions. It is thought that they will become valuable tools for controlling inflammatory and immune responses. The chapter discusses the positive role of statins in the treatment of autoimmune reactions. The identification of several mechanisms through which statins decrease the recruitment of macrophages and T cells into the arterial wall and inhibit T-cell activation and proliferation in vitro have confirmed speculations that the immunomodulatory effects of statins may also be beneficial in the prevention of cardiovascular events. Many of these effects are related to the inhibition of isoprenoid synthesis, which serves as a lipid attachment for a variety of proteins implicated in intracellular signaling.

AB - Statins may provide benefits, both by decreasing cholesterol and by the use of lipid-independent mechanisms. Extensive research carried out recently suggests that the clinical benefits of these drugs could be related to an improvement in endothelial dysfunction, a reduction in blood thrombogenicity, anti-inflammatory properties, and immunomodulatory actions. It is thought that they will become valuable tools for controlling inflammatory and immune responses. The chapter discusses the positive role of statins in the treatment of autoimmune reactions. The identification of several mechanisms through which statins decrease the recruitment of macrophages and T cells into the arterial wall and inhibit T-cell activation and proliferation in vitro have confirmed speculations that the immunomodulatory effects of statins may also be beneficial in the prevention of cardiovascular events. Many of these effects are related to the inhibition of isoprenoid synthesis, which serves as a lipid attachment for a variety of proteins implicated in intracellular signaling.

UR - http://www.scopus.com/inward/record.url?scp=67649646273&partnerID=8YFLogxK

U2 - 10.1016/S1571-5078(03)01007-9

DO - 10.1016/S1571-5078(03)01007-9

M3 - Chapter

SN - 9780444513984

VL - 1

T3 - Handbook of Systemic Autoimmune Diseases

SP - 97

EP - 106

BT - The Hearth in Systemic Autoimmune Diseases

A2 - Doria, A.

A2 - Pauletto, P.

PB - Elsevier

ER -

ID: 4623612